AlphaFold predicted structure
LAGE3 · Q14657

Mean pLDDT
74.1/ 100
Confident
143 residues
Confidence breakdown
- Very high(≥ 90)41%
- Confident(70–90)13%
- Low(50–70)32%
- Very low(< 50)14%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
L antigen family member 3
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Fetal anomalies
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesProteinuric renal disease
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesSevere microcephaly
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesDDG2P
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesGalloway-Mowat syndrome 2, X-linked
neurodegenerative disease
Galloway-Mowat syndrome
lysosomal storage disease
hepatocellular carcinoma
breast cancer
neoplasm
autosomal recessive spondylocostal dysostosis
cancer
spondylolisthesis
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
EKC/KEOPS complex subunit LAGE3
Component of the EKC/KEOPS complex that is required for the formation of a threonylcarbamoyl group on adenosine at position 37 (t(6)A37) in tRNAs that read codons beginning with adenine (PubMed:22912744, PubMed:27903914). The complex is probably involved in the transfer of the threonylcarbamoyl moiety of threonylcarbamoyl-AMP (TC-AMP) to the N6 group of A37 (PubMed:22912744, PubMed:27903914). LAGE3 functions as a dimerization module for the complex (PubMed:22912744, PubMed:27903914)
LAGE3 · Q14657

Mean pLDDT
74.1/ 100
Confident
143 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0